Shareholders could reduce the toxicity of corporate boards’ use of a “poison pill”—a device designed to block shareholders from considering a takeover bid—if they could replace board majorities more quickly, writes Harvard Law School Professor Lucian Bebchuk LL.M. ’80 S.J.D. ’84 in an op-ed that appeared in the Feb. 24, 2011, edition of the Wall Street Journal.
Harvard Law School’s faculty earned the top ranking for the number of academic papers authored and downloaded on the Social Science Research Network (SSRN), according to cumulative statistics released for 2010. HLS faculty members captured 10 of the top 100 slots–including the number one slot–among the top 100 law school professors (in all legal areas) in terms of readers’ use of their work.
The Social Science Research Network recently announced the distribution of a new e-journal on Bankruptcy, Financial Distress, & Reorganization provided by Corporate Governance Network (CGN).
HLS’s Program on Corporate Governance—and many individuals affiliated with HLS—are among the most influential leaders in the study of corporate governance, according to a recent review by Directorship magazine. Thirty-four HLS-affiliates made the Directorship 100 list – an annual list of the 100 most influential directors, professors, regulators, politicians, and advisers who have made a lasting impact on corporate governance.
This op-ed co-written by Harvard Law School Professor Lucian Bebchuk LL.M. ’80 S.J.D. ’84 and Holger Spamann, “Reducing incentives for risk-taking,” appeared in the October 12, 2009, edition of the New York Times. Bebchuk is a professor of law, economics and finance and director of the Program on Corporate Governance at Harvard Law School, and Spamann is co-executive director and a fellow of the HLS corporate governance program. Their op-ed builds on their joint paper, “Regulating Bankers’ Pay.”